Market Cap:
$ SEC Filings
Filing | Filed On |
---|---|
SC 13D/A | 14 Jan 2022 |
57.24% INTEREST IN INFECTECH | 07 Nov 2003 |
REGENESIS CAPITAL AMENDMENT SC13D | 09 Oct 2003 |
SCHEDULE 13D AMENDMENT | 06 Oct 2003 |
SCHEDULE 13D AMENDMENT | 03 Oct 2003 |